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 Executive Summary 
The 2019 Massachusetts Department of Public Health’s (MDPH) Arbovirus Surveillance and Response 
plan provides surveillance and phased response guidance for arthropod-borne viruses (arboviruses) 
affecting Massachusetts residents, West Nile virus (WNV) and eastern equine encephalitis virus (EEE), in 
particular. Since 2000, there have been 203 cases of WNV among Massachusetts residents resulting in 
at least 12 deaths and 26 cases of EEE resulting in at least 14 deaths. This plan reflects a 
comprehensive review of surveillance activities, mosquito control efforts, public information, and risk 
communication related to arbovirus control in Massachusetts.  
 
The purpose of the plan is to provide guidance on operational aspects of surveillance and response by 
state and local agencies responsible for the prevention of mosquito-borne disease in the 2019 season. 
MDPH will continue to seek advice from its partners and collaborators and modify the plan, as 
appropriate. This document is open to continual review and evaluation. Information is provided to guide 
planning and actions to reduce the risk of human disease from endemic arbovirus including EEE and 
WNV, and to respond to concerns about the introduction of Zika virus, or other emerging arboviruses, into 
regions of the Americas.  
 
This plan does not address long-term, municipal planning activities. WNV and EEE are endemic diseases 
in Massachusetts which, although rare, are serious and likely to pose continued threats to human health. 
Municipalities are encouraged to consider these threats, identify contributing issues in their communities, 
and include mitigation activities as part of sustainable community development (e.g. source reduction, 
low-impact development). 
 
Key components of the plan include:  
 
 monitoring trends in EEE and WNV activity in Massachusetts;  
 timely collection and dissemination of information on the distribution and intensity of WNV and EEE in 
the environment;  
 laboratory diagnosis of WNV and EEE cases in humans, horses and other animals;  
 effective communication, advice, and support of activities that may reduce risk of infection;  
 phased response to provide measures to suppress the risk of infection; and 
 monitoring for evidence of introduced and emerging arboviruses and new mosquito vector species. 
 
This document provides information about EEE and WNV disease and program goals, and specific 
guidelines for mosquito, equine, and human surveillance. Additionally, this document provides guidance 
for the dissemination of information, including routine information; media advisories of positive EEE and 
WNV findings in mosquitoes, as well as public health alerts related to positive EEE and WNV human 
cases.              
 
This plan describes MDPH’s public outreach efforts to provide helpful and accurate communication with 
Massachusetts residents about their risk from arboviral diseases and specific actions that individuals and 
communities can take to reduce this risk. Routine precautions should include: avoiding outdoor activity 
during times of day with increased mosquito activity; use of mosquito repellents containing an EPA-
approved active ingredient; and use of clothing to reduce mosquito access to skin. These personal 
protective measures form the basis of all risk reduction; the need to utilize them is not reduced by any 
mosquito control activities, including aerial spraying. 
 
I.   INTRODUCTION 
 
The Massachusetts Department of Public Health, in collaboration with the State Reclamation and 
Mosquito Control Board (SRMCB) and regional mosquito control projects (MCP), conducts surveillance 
for mosquito-borne viruses that pose a risk to human health. Surveillance currently focuses on West Nile 
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and eastern equine encephalitis viruses, which are found in the local environment and are capable of 
causing serious illness and death in humans, horses, and other mammals.  
 
The 2019 Massachusetts Surveillance and Response Plan for mosquito-borne diseases is based on a 
comprehensive plan initially developed for WNV in 2001 in collaboration with local health agencies, other 
state agencies, academic institutions, the Centers for Disease Control and Prevention (CDC), and 
interested groups and individuals. It incorporates components of the state’s EEE surveillance activities, 
which began in the 1950s and have continued since that time. Monitoring for WNV began following a 
1999 outbreak of human WNV disease in the New York City area, the first known occurrence of this 
disease in North America. WNV was identified in birds and mosquitoes in Massachusetts during the 
summer of 2000, in humans in 2001, and has been detected during each consecutive season.  
 
The updated 2019 plan is the result of analyses of surveillance data collected in Massachusetts and the 
United States. In order to address the complexity and seriousness of the human disease risk posed by 
EEE, MDPH convened a panel of experts in 2011-2012 who represented the fields of ecology, biology, 
public health, infectious disease, and toxicology to review MDPH’s surveillance and response program 
and make recommendations for enhancing the program. Those recommendations were incorporated into 
the plan in 2012 and continue to serve as important components of the current plan. In addition, MDPH 
continues to promote collaborative efforts with multiple agencies and interest groups by seeking and 
accepting comment from stakeholders. The purpose of the plan is to provide guidance on operational 
aspects of surveillance and response by state and local agencies with responsibilities for the prevention 
of mosquito-borne disease. MDPH will continue to seek advice from its partners and collaborators, and 
modify the plan, as appropriate. This document is open to continual review and evaluation, with changes 
made when there is opportunity for improvement.  
 
II. DISEASE HISTORY AND BACKGROUND 
 
A. Eastern Equine Encephalitis Virus 
 
1. Background 
Eastern equine encephalitis is a serious disease which occurs sporadically in Massachusetts, with 30-
50% mortality and lifelong neurological disability among many survivors. The first symptoms of EEE are 
fever (often 103º to106ºF), stiff neck, headache, and lack of energy. These symptoms show up three to 
ten days after a bite from an infected mosquito. Inflammation and swelling of the brain, called 
encephalitis, is the most dangerous and frequent serious complication. The disease rapidly worsens and 
some patients may go into a coma within a week. There is no treatment for EEE. In Massachusetts, 
approximately half of the people identified with EEE have died from the infection. People who survive this 
disease will often be permanently disabled due to neurologic damage. Few people recover completely.  
 
Historically, clusters of human cases have occurred over a period of two to three years, with a variable 
number of years between clusters. In the years between these case clusters or outbreaks, isolated cases 
can and do occur. Outbreaks of human EEE disease in Massachusetts occurred in 1938-39, 1955-56, 
1972-74, 1982-84, 1990-92, and, 2004-06. Two cases of EEE occurred in each of 2010 and 2011; one 
case each of these years occurred in visitors to Massachusetts.  Seven human cases of EEE occurred in 
2012, a single case in 2013 and no cases from 2014 - 2018. 
 
Massachusetts Eastern Equine Encephalitis Experience 
Year(s) Human EEE Cases Human EEE Deaths 
1938-39 35 25 
1955-56 16 9 
1973-74 6 4 
1982-84 10 3 
1990-92 4 1 
2000-01 2 0 
2004-06 13 8 
2008 1 1 
2010-11 2 (plus 2 non-residents) 1   
2 
 
2012 7 3 
2013 1 1 
2014-2018 0 0 
 
The U.S. Public Health Service, in collaboration with MDPH, initiated a field surveillance program in 1957; 
following a 1955-56 outbreak of EEE. The purpose of the program was to gather data to guide prevention 
and risk reduction for this disease. This program formed the basis for the Commonwealth’s current 
arbovirus program. 
 
2. Risk Factors for Disease Transmission 
Eastern equine encephalitis virus is a virus in the genus Alphavirus that is native to the Massachusetts 
environment (enzootic) and is naturally found in some passerine (perching) bird species living in and 
around fresh-water swamp habitats. These habitats also support populations of the primary mosquito 
vector, Culiseta melanura, which feeds predominantly on birds. The swamp habitats, which support large 
populations of Cs. melanura and are the initial source of EEE, are known as enzootic foci. Although 
portions of the ecology of EEE virus have yet to be clarified, the virus has a cycle of natural infection 
among bird populations with occasional ‘‘incidental” symptomatic infections in susceptible species, 
including humans. The appearance of EEE in late June or early July coincides with the hatching of highly 
susceptible bird populations. The virus is circulated among the bird populations by Cs. melanura and 
under some circumstances Cs. morsitans, another bird-biting mosquito. Initially, a relatively smaller 
proportion of birds and mosquitoes carry the virus; throughout the mosquito season, continuous 
transmission between mosquito vectors and bird reservoir hosts increases the proportion of infected birds 
and mosquitoes leading to an overall greater amount of virus present in the environment. This is called 
the virus amplification cycle. Depending on when virus circulation begins, the size of the Culiseta 
populations, weather conditions, and probably additional, currently unidentified factors, this virus 
amplification cycle may eventually spill over and involve secondary, or "bridge", mosquito vectors that 
feed on both birds and mammals. In the Northeast, these bridge vectors are mosquito species, such as 
Coquillettidia perturbans, Ochlerotatus (formerly Aedes) canadensis, and Aedes vexans. These bridge 
vectors are presumed to be responsible for the transfer of EEE to incidental hosts, including mammals 
such as humans, horses, llamas, and alpacas; and large birds such as emus and ostriches. For the 
purposes of risk assessment and communication with the public, Cs. melanura is considered to be and 
will be reported as a “bird-biter” while C. perturbans, O. canadensis, and A. vexans are considered to be 
and will be reported as “mammal-biters”. Culex species mosquitoes found positive for EEE are not 
considered to play a significant role in transmission of the virus to humans or animals and are considered 
to be and will be reported as bird-biters. 
 
In the Northeast, the EEE enzootic foci are large hardwood swamps of mature white cedars and red 
maples. To grow in the permanently wet swamps, tree roots spread out across the peat soils 
characteristic of these habitats. These root systems create dark holes, or crypts, that are generally filled 
with water. These crypts are the preferred ovipositing (egg-laying) sites for Cs. melanura and are where 
the larvae develop. Cs. melanura survives the winter as larvae in these crypts. The amount of rainfall 
during the summer and fall affects the survival of the larvae during the winter and, in part, determines the 
population of adult mosquitoes the following year.    
 
The risk of EEE in humans varies by geographical area in Massachusetts, as well as in the United States, 
and is correlated with the location of the necessary swamp habitats. In Massachusetts, these areas occur 
across the state, but are most common in southeastern Massachusetts. The majority of EEE cases have 
occurred in Norfolk, Bristol, and Plymouth counties, with some cases also occurring in Essex and 
Middlesex County (Figure 1). A very few cases have also occurred further west in Massachusetts. 
Historically, Barnstable and the Islands of Martha’s Vineyard and Nantucket have not had human cases 
of EEE. 2012 was unusual in that five of seven human cases and four of seven animal cases resided 
outside southeastern Massachusetts. The significance of this is unclear at present; this may or may not 
be a harbinger of more widespread risk in Massachusetts. The situation has been closely monitored since 
then and there was early evidence of EEE activity in one of these areas which resulted in two horses 
infected with EEE in 2013.  
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Currently, it is impossible to predict, with complete accuracy, the appearance of EEE and the probability 
of human EEE infection in any given year. However, over 50 years of surveillance for EEE in 
Massachusetts has enabled the development of a mosquito-based EEE surveillance system and the 
identification of several factors that help provide an estimate of human risk. These estimates are used to 
alert the residents of the state and guide mosquito control activities. Risk estimates are based on the 
current level of EEE activity in both bird-biting and mammal-biting mosquito species, population levels of 
these species, timing of virus identification in these species, recent and historic levels of EEE activity, and 
prevailing weather conditions.   
 
Human cases are more likely when multiple factors indicate that risk is increasing in a given place at a 
given time. Identification of EEE in the enzootic mosquito vector, Cs melanura, is useful for determining 
areas of virus amplification and as a proxy measure of the amount of EEE virus in the environment. The 
overall amount of EEE virus present in the environment correlates with the population size of the primary 
mosquito vector, Cs melanura.  Abundant populations of this species provide greater opportunity for the 
virus to perpetuate or amplify within the bird population. Theoretically, the more virus that is circulating 
between mosquitoes and birds, the more likely it will be to be picked up by a bridge vector mosquito and 
transmitted to humans. Identification of EEE in bridge vector mosquito species confirms the presence of 
infected mosquitoes of a species known to feed on humans. The more virus that has spilled over into 
bridge vector species, the greater the chance that a person will be exposed to the virus. Warm 
temperatures increase the rate of both mosquito development and virus replication within mosquitoes. 
Consistently elevated temperatures increase mosquito populations of all species, speed up virus 
multiplication within mosquitoes, and therefore act to increase the amount of virus in the environment 
overall. 
 
Other factors that affect the risk of EEE infection for humans are the abundance of key mosquito species 
at critical periods of the transmission season, groundwater levels, and the timing of rainfall and flooding 
during the mosquito season. Long-term weather patterns during the fall and winter that produce high 
ground water levels and snow cover may enhance survival of Cs. melanura larvae. The abundance of 
these larval populations may serve as an early indicator of the potential for human disease later in the 
year. 
 
Multiple factors affect the development, survival, and abundance of mosquitoes. It is not currently 
possible to accurately forecast either the abundance of mosquitoes or the risks for encountering an 
infected vector later in the season. Risk assessment relies upon a robust mosquito surveillance system to 
monitor both mosquito populations and virus amplification as the season progresses. 
 
B. West Nile Virus 
 
1. Background                                                                                                                                                                                                       
West Nile virus (WNV) first appeared in the United States in 1999. Since the initial outbreak in New York 
City, the virus has spread across the US from east to west. Following the identification of WNV in birds 
and mosquitoes in Massachusetts during the summer of 2000, MDPH arranged meetings between local, 
state, and federal officials, academicians, environmentalists and the public to develop recommendations 
to adapt the arbovirus surveillance and response plan to include activities appropriate for WNV. Four 
workgroups addressed the issues of surveillance, risk reduction interventions, pesticide toxicity, and 
communication. 
 
WNV infection may be asymptomatic in some people, but it leads to morbidity and mortality in others.  
WNV causes sporadic disease of humans, and occasionally significant outbreaks. Nationally, 2,554 
human cases of WNV neuroinvasive disease (meningitis and encephalitis) and WNV fever were reported 
to the CDC in 2018. The majority of people who are infected with WNV (approximately 80%) will have no 
symptoms. A smaller proportion of people who become infected (~ 20%) will have symptoms such as 
fever, headache, body aches, nausea, vomiting, and sometimes swollen lymph glands. They may also 
develop a skin rash on the chest, stomach, and back. Less than 1% of people infected with WNV will 
develop severe illness, such as encephalitis or meningitis. The symptoms of severe illness can include 
high fever, headache, neck stiffness, stupor, disorientation, coma, tremors, convulsions, muscle 
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weakness, vision loss, numbness, and paralysis. Persons older than 50 years of age have a higher risk of 
developing severe illness. In Massachusetts, there were at least 12 fatal WNV human cases identified 
between 2002 and 2018. All but three of these fatalities were in individuals 80 years of age or older; all of 
them were in individuals over 60.                                                                                                                                                                                    
 
2. Risk Factors for Disease Transmission 
West Nile virus is amplified by a cycle of continuous transmission between mosquito vectors and bird 
reservoir hosts. Infected mosquitoes carry virus and transmit it to susceptible bird species. WNV infection 
can be fatal in some species of birds, particularly American crows and blue jays (corvids). Confirmation of 
WNV in dead birds historically provided sentinel information used for assessing the risk of human WNV 
infections. However, the proportion of susceptible birds has decreased over time so that testing dead 
birds for the presence of virus is no longer an efficient surveillance tool. 
 
The principal mosquito vectors for West Nile virus on the East Coast are members of the genus Culex, 
primarily C. pipiens and C. restuans. These species may be abundant in urban areas, breeding easily in 
artificial containers, such as birdbaths, discarded tires, buckets, clogged gutters, catch basins, and other 
standing water sources. Both species feed mainly on birds and occasionally on mammals, including 
humans. Peak feeding activity for these species occurs from dusk into the late evening. Consistently high 
temperatures and lower precipitation rates are factors that have been associated with higher mosquito 
infection and human illness rates. Additionally, warmer winter temperature conditions may result in larger 
numbers of Culex species overwintering as adults, with resulting increases in early season Culex 
abundance. 
   
There are additional mosquito species in Massachusetts that can be involved in the transmission of WNV 
to humans. Culex salinarius lives in brackish and freshwater wetlands and feeds on amphibians, birds, 
and mammals; it is well known for biting humans. Ochlerotatus japonicus may be involved in the 
transmission of both WNV and EEE. This species utilizes natural and artificial containers, such as tires 
and rock pools as larval habitat. It feeds mainly on mammals and is an aggressive human biter. Unlike 
EEE, distinguishing between bird- and mammal-biting species of mosquitoes is of less importance for risk 
assessment purposes and these designations are not routinely used. 
 
West Nile virus activity varies from year to year. When large numbers of infected birds and elevated 
mosquito populations occur in a relatively small geographic area, the result is a high mosquito infection 
rate and an increased risk of transmission of virus to humans. In addition, there is evidence that when 
meteorologic conditions are such that Cx. pipiens populations are increased relative to Cx. restuans, the 
risk of transmission to humans may be increased. Surveillance evidence indicates that WNV is 
established in the United States and that virus activity is likely to occur annually. 
 
Most municipalities in Massachusetts will only have sporadic human cases of WNV and are unlikely to 
have more than one year. However, several highly urbanized areas in Massachusetts have accounted for 
over 80% of the human WNV infections between 2001 and 2018 (Figure 2). 
 
Summaries of historical surveillance information for EEE and WNV in Massachusetts are available online 
at www.mass.gov/dph/mosquito. During the season, information is provided daily with current surveillance 
information and risk assessments which can be found through the same site. 
 
III. PROGRAM GOALS 
 
Timely and accurate information based on surveillance information is used to provide an estimate of the 
level of risk for human disease from WNV and EEE. Based on this surveillance information, plans and 
actions to reduce risk can be developed and implemented when needed. Program activities include: 
 
 Testing mosquitoes, horses, other appropriate animals, and humans to identify EEE and WNV 
infections; 
 Tracking trends in incidence and prevalence of EEE and WNV infections by geographic area; 
 Estimating viral infection rates in mosquitoes; 
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 Stratification of risk by geographic areas as a function of relative risk of human disease;  
 Conducting surveillance for human and animal disease; 
 Educating human and animal medical practitioners on the appropriate procedures for detecting 
infections and disease caused by mosquito-borne viruses; 
 Recommending measures to reduce virus transmission and disease risk; 
 Educating the public on mosquito-borne diseases and disease risk and common-sense 
precautions to reduce the risk of infection;  
 Working to detect emerging arboviruses, such as Jamestown Canyon virus, and introduced 
arbovirus infections in travelers to areas with transmission of these arboviruses, such as dengue, 
chikungunya and Zika viruses; 
 Working to detect the introduction, establishment and geographic spread of new mosquito vector 
species; and 
 Participating in the national Arbovirus Surveillance Network. 
 
IV. AGENCY ROLES 
 
A. Massachusetts Department of Public Health (MDPH)  
 
The central purpose of arbovirus surveillance is to provide information that will guide planning and 
activities to reduce the risk of human disease from EEE and WNV infection. To achieve this, the main 
objectives are to monitor trends in EEE and WNV in Massachusetts; provide timely information on the 
distribution and intensity of WNV and EEE activity in the environment; perform laboratory diagnosis of 
WNV and EEE cases in humans, horses and other animals; communicate effectively with officials and the 
public; provide guidelines, advice, and support on activities that effectively reduce risk for disease; and 
provide information on the safety, anticipated benefits, and potential adverse effects of proposed 
prevention interventions. The arbovirus surveillance program should also have the capacity to respond to 
concerns about the introduction of travel-associated diseases, like Zika virus, by monitoring for evidence 
of introduced and emerging arboviruses and new mosquito vector species 
 
MDPH works cooperatively with the SRMCB, regional mosquito control projects, local health 
departments, and other agencies to collectively identify and support the use of safe and effective 
mosquito control measures based on integrated pest management (IPM) principles. The use of pesticides 
as a means to reduce human risk is one of several methods used as part of an overall strategy. 
 
B. State Reclamation and Mosquito Control Board (SRMCB) 
 
The SRMCB oversees mosquito control programs and activities in the Commonwealth of 
Massachusetts. The SRMCB consists of three members representing the Department of Agricultural 
Resources (DAR), Department of Conservation and Recreation (DCR), and Department of Environmental 
Protection (DEP).  Additionally, the SRMCB advises its respective state agency Commissioners on 
actions to reduce mosquito populations based on MDPH findings and characterization of risk.   
 
The SRMCB’s ‘Operational Response Plan to Reduce the Risk of Mosquito-Borne Disease in 
Massachusetts’ addresses the issues related to the operational aspects of adult mosquito surveillance 
and control to prevent and/or reduce the risk of mosquito-borne diseases. The plan may be accessed 
online from https://www.mass.gov/massachusetts-emergency-operations-response-plan-for-mosquito-
borne-illness 
 
 In 2006,  the SRMCB created the Mosquito Advisory Group (MAG) to provide independent, scientific 
advice to the SRMCB regarding the justification, timing, location and options for intervention tactics such 
as to prevent and/or suppress and contain infected mosquito populations that may otherwise result in an 
outbreak of disease in people and animals. 
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C. Mosquito Control Projects (MCPs) 
 
There are 11 organized Mosquito Control Projects or Districts located throughout Massachusetts; in 2018 
the Pioneer Valley Mosquito Control Project was officially approved and is in the development phase for 
service offerings. All of the mosquito control activities of these agencies are performed under the aegis of 
the SRMCB. MCPs collaborate with local boards of health in their jurisdictions to perform public 
education, promote the use of personal protection and to control mosquitoes. Locally authorized mosquito 
control efforts employ a variety of targeted activities for source reduction, larviciding and adulticiding that 
are in compliance with the SRMCB Operational Response plan. Additional details relating to MCPs may 
be found within the SRMCB Operational Plan and online at  
https://www.mass.gov/state-reclamation-and-mosquito-control-board-srmcb 
https://www.mass.gov/massachusetts-emergency-operations-response-plan-for-mosquito-borne-illness 
 
D. Local Boards of Health (LBOHs) 
 
LBOHs are the local health authorities and the primary points of contact within a community for MDPH. 
Surveillance information is communicated to the LBOH who may work with their MCP (if any) to 
determine mosquito control response activities, conduct educational outreach via the media and/or other 
means, investigate cases, disseminate surveillance and risk assessment information to other community 
leaders and undertake other activities based on their community’s needs. 
 
V. SURVEILLANCE  
 
A. Mosquito Surveillance 
 
Surveillance of certain species of mosquitoes for arboviruses is a core function of MDPH. Although there 
are up to 51 species of mosquitoes found in Massachusetts, only species involved in the spread of 
disease are tested for surveillance purposes. Monitoring mosquitoes for the presence of virus provides an 
estimate of risk to humans. Massachusetts has a long-term field surveillance program that was initiated in 
1957 for EEE and was enhanced in 2000 to include WNV surveillance. The extensive experience in 
Massachusetts with surveillance for mosquito-borne disease provides expertise and capacity to guide risk 
reduction efforts. MDPH uses a comprehensive and flexible strategy that modifies certain surveillance 
activities in response to trends in disease risk.  
 
On an ongoing basis, MDPH monitors national and regional surveillance data and current scientific 
literature to assess risk of newly emerging arboviruses in Massachusetts. In addition, a defined subset of 
mosquitoes will be tested for the presence of new or emerging viruses using tissue culture methods. 
 
1. Fixed and Long-Term Trap Sites   
MDPH field staff trap mosquitoes at long-term sites maintained primarily in the EEE high-risk areas of 
southeastern and eastern Massachusetts (Figure 2) and from other areas as circumstances demand and 
resources allow. Trapping of gravid (egg-bearing) mosquitoes for WNV testing is conducted both by 
MCPs and MDPH field staff at various locations throughout the state during the arbovirus season. After 
trapping, all collected mosquitoes are sorted into groups by species and counted by hand. At the 
Massachusetts State Public Health Laboratory (MA SPHL), these samples (grouped or pooled sets of 10- 
50 mosquitoes) for WNV and EEE. These are frequently referred to as “mosquito pools” which indicates 
the grouping of mosquitoes for testing purposes and is not a reference to any body of water. Test results 
from routine mosquito collections are usually available within 24 hours after delivery of mosquitoes to the 
MA SPHL. Routine collections from fixed and long-term trap sites provide the best available baseline 
information for detecting trends in mosquito abundance and virus prevalence, and for estimating the 
relative risk for human infection from EEE virus and WNV. MDPH field staff monitor larvae from select 
sites in late fall and early spring to determine end-season and pre-season larval abundance. Informal 
monitoring of larval abundance from these sites continues on a weekly basis during the arbovirus season. 
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2. Supplemental Trap Sites  
When EEE or WNV activity is detected in an area, additional trap sites and/or trap types are used 
to obtain more information regarding the intensity of virus activity in mosquitoes. The following 
risk indicators may result in the implementation of more intensive mosquito trapping: 1) virus 
isolations in mosquitoes; 2) emergence of large numbers of human-biting mosquitoes in an area 
with a high rate of virus activity and 3) identification of human or animal cases. 
 
3. Mosquito Control Project Trap Sites   
MCPs use a variety of available control strategies to impact mosquito abundance. Monitoring mosquito 
abundance is accomplished through various surveillance methods including but not limited to larval dip 
counts and the use of light/ CO2 baited traps and gravid traps.  
 
4. Results 
Results of mosquito trapping and testing provide information on: 
 the numbers of positive mosquito samples (mosquito pools) from a community;   
 general measures of mosquito populations; and  
 relative EEE infection rates in mosquito populations. 
 
B.  Avian Surveillance 
 
MDPH discontinued avian surveillance for WNV as of April, 2009. When the virus was first introduced into 
the United States, WNV caused high mortality rates in certain species of birds, particularly corvids, thus 
reporting and testing of dead birds was a productive way to detect and monitor WNV activity in an area. 
However, in recent years, the tracking and testing of dead birds has become significantly less useful as a 
surveillance tool. Monitoring mosquitoes for presence of virus is the primary predictive indicator of human 
arbovirus disease risk. Therefore, the routine laboratory testing of dead wild birds for West Nile virus 
(WNV) has been eliminated. This is consistent with recent policy changes in multiple states.  
 
Most birds that are infected with EEE virus survive the viremia, making individual dead bird EEE 
monitoring impractical. Non-native bird species such as emus, ostriches, and exotic game birds 
are highly susceptible to EEE and infections within farmed flocks have occurred in 
Massachusetts. Testing of highly suspect bird specimens for EEE and/or WNV infection is done 
on an as-needed basis as determined by MDPH. 
 
C.  Animal Surveillance  
 
Specimens from horses and other domestic animals that have severe neurological disease suspected of 
being caused by EEE or WNV infection are tested at the MA SPHL. Testing can take up to several weeks 
to complete depending upon the type of sample submitted and the testing protocol required to obtain a 
definitive result. Veterinarians, DAR, the United States Department of Agriculture (USDA) and Tufts 
University Cummings School of Veterinary Medicine collaborate with MDPH to identify and report suspect 
animal cases. In addition, blood and/or tissue samples from animals from other sources, such as zoos, 
horse stables, or the wild are tested, as appropriate. Current information on WNV and EEE infections in 
horses, along with clinical specimen submission procedures, are disseminated to large animal 
veterinarians, stable owners, and others through various distribution methods and are posted on the 
MDPH arbovirus website at https://www.mass.gov/mosquito-borne-diseases Horses and other animals 
can be immunized against infection with WNV and EEE with available veterinary vaccines. Vaccination is 
the primary means of preventing infection in animals.  
 
Due to the time delay inherent in specimen acquisition and testing, specimens from animal with an illness 
compatible with either WNV or EEE infection that test positive on the screening test will be reported as a 
preliminary result to the ordering veterinarian, the local board of health in the town of the animal’s 
residence, the local board of health in the likely city/town of exposure (if different from place of residence), 
and the local mosquito control project, if there is one. This information may be used to inform clinical 
decisions first and foremost, and secondarily to inform planning for public health and mosquito control 
8 
 
activities. This animal will not be considered to represent a confirmed case until testing is completed; 
appropriate changes to risk levels will be made following confirmatory testing.  
 
D. Human Surveillance 
 
1. Routine surveillance  
Specimens from human cases of encephalitis and meningoencephalitis should be submitted to the MA 
SPHL for WNV and EEE testing. Testing for both viruses usually consists of a preliminary screening test 
(an enzyme immunoassay for antibody to the viruses), followed by confirmatory testing by plaque 
reduction neutralization test (PRNT) for specific antibody. Certain specimens, cerebrospinal fluid drawn 
shortly after symptom onset, may be tested by polymerase chain reaction (PCR). Only specimens that are 
positive on the confirmatory PRNT test or on PCR at the MA SPHL are considered to represent true 
cases and will be used for risk assessment. Increasing availability of commercial laboratory testing for 
WNV has diverted submission of samples away from the MA SPHL. Current commercially available 
testing is equivalent to the screening test that MDPH runs, but does not extend to the confirmatory testing 
capability available at the MA SPHL. Not all specimens reported to be positive based on commercial 
laboratory testing will confirm with the more specific confirmatory testing that is performed by the MA 
SPHL. Only those tests that are confirmed positive (through testing at the MA SPHL) will be officially 
reported out. Specimens from any individual reported to be positive based on commercial laboratory 
testing will be requested for additional testing. 
 
Testing may take several weeks to complete dependent upon the type of sample submitted and the 
testing protocol necessary to obtain a definitive result.  Under certain circumstances, definitive results 
cannot be obtained by the MA SPHL and samples are forwarded to the Centers for Disease Control and 
Prevention (CDC) for additional testing. Time to receipt of final results from CDC is variable. Current 
information on WNV and EEE infections in humans, along with clinical specimen submission procedures, 
are disseminated to physicians (infectious disease, emergency medicine and primary care), emergency 
department directors, hospital infection control practitioners, and local boards of health through various 
distribution methods and are posted on the MDPH arbovirus website at https://www.mass.gov/mosquito-
borne-diseases. 
 
Due to the time delay inherent in specimen acquisition and testing, specimens from patients with an 
illness compatible with either WNV or EEE infection that test positive on the screening test will be 
reported as a preliminary result to the ordering provider, the local board of health in the town of the 
patient’s residence, the local board of health in the likely city/town of exposure (if different from place of 
residence), and the local mosquito control project, if there is one. This information may be used to inform 
clinical decisions first and foremost, and secondarily to inform planning for public health and mosquito 
control activities. These patients will not be considered to represent confirmed cases until testing is 
completed; appropriate changes to risk levels will be made following confirmatory testing. Samples 
reported to be preliminarily positive from blood donor screening programs will also be reported to the local 
board of health and the mosquito control project, if there is one, for similar reasons. 
 
Because antibodies to WNV can persist for months, a positive laboratory test alone does not necessarily 
indicate evidence of current infection. Laboratory data must be correlated with clinical information and 
exposure risk in order to identify current, confirmed cases for the purposes of surveillance. The frequency 
of positive laboratory tests from individuals who otherwise do not appear to represent true, current 
instances of infection will be highest immediately following very active years, such as occurred in 2012. 
 
2. Active surveillance  
If surveillance data estimate a high risk of human disease, active surveillance may be instituted in 
targeted areas. Active surveillance involves regularly contacting local health care facilities to 
communicate current surveillance information, promoting disease prevention strategies, reviewing 
specimen submission procedures, and highlighting the need for testing patients presenting with signs and 
symptoms possibly representing infection with EEE virus or WNV. The Health and Homeland Alert 
Network (HHAN), a secure electronic alerting system, is used to send information to local boards of health 
upon confirmation of EEE or WNV in any specimen. 
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3. Pesticide related surveillance  
Outreach on pesticide illness reporting is coordinated by the MDPH’s Bureau of Environmental Health. In 
the event of an aerial pesticide application, active surveillance efforts will be implemented with emergency 
departments and intensified outreach efforts will be made to health care providers. 
 
VI. COMMUNICATION OF CONFIRMED SURVEILLANCE INFORMATION 
 
MDPH works with the SRMCB and MCPs to identify and support the use of risk reduction and disease 
prevention methods that are specific to the causes of disease, and supports planning and practices which 
incorporate the most appropriate prevention methods. Additionally, MDPH routinely communicates with 
health agencies in neighboring states to share relevant arbovirus findings. 
 
Prior to the beginning of the arbovirus season, general disease information and specimen submission 
procedures are provided to local boards of health via the HHAN. The local boards of health (LBOH) are 
asked to provide routine and emergency contact information for a primary and secondary arbovirus 
contact during the season. Although routine surveillance specimen notifications are scheduled during 
normal business hours, test results sometimes become available after hours. General information and 
fact sheets are posted on the MDPH arbovirus website and are available publicly. 
 
Summaries of surveillance findings are compiled and released in weekly reports issued on Monday 
afternoons to local boards of health and mosquito control projects. 
 
Initial identification of virus in mosquitoes from a given town is reported to the LBOH and MCP by 
telephone. Adjacent towns are notified via a moderate level HHAN alert. In order to encourage risk 
communication on a larger area level rather than a city/town level, all subsequent positive findings in 
mosquitoes are reported once daily to all affected towns and adjacent towns, via a moderate level HHAN 
alert. All subsequent positive mosquito findings will also be reported once daily to all MCPs and the 
SRMCB. 
 
Laboratory confirmation of a human WNV or EEE case is immediately reported to the submitting 
physician, submitting laboratory and LBOH in the town where the case resides. If the LBOH cannot be 
reached in a timely manner, a severe level HHAN alert is sent. 
 
Laboratory confirmation of WNV or EEE in a veterinary specimen is immediately reported by telephone to 
the submitting veterinarian, the MDAR Division of Animal Health, and the LBOH. If the LBOH cannot be 
reached via telephone in a timely manner, a severe level HHAN alert is sent.  
 
Risk assessment changes will be reported to the LBOH, the MCP and any immediately adjacent 
community. Routine risk assessment level changes from low to moderate will be done twice per week, on 
Mondays and Thursdays. Assessed changes to high or critical will be communicated immediately.  
 
The MDPH Regional Health Office (RHO) and the Office of Preparedness and Emergency Management 
(OPEM) Regional Public Health Preparedness Coordinator in the area can offer assistance with local 
response. All laboratory confirmed results for WNV and EEE in humans, veterinary specimens, and 
mosquitoes are provided to the RHO, OPEM, MCPs and members of the SRMCB once the LBOH has 
been notified. 
 
At the time of notification, MDPH encourages LBOH to share the information with other local agencies 
and high-risk populations in their community, as appropriate. MDPH provides LBOH with sample press 
releases for their use. Depending on the circumstances, MDPH may also issue a public health alert. In 
addition, weekly summaries of results from mosquito samples submitted and tested will be posted by 
town as News Items on the HHAN.  
 
After all appropriate individuals and agencies have been notified, positive surveillance findings are made 
available to the media and general public on the MDPH Arbovirus website at 
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http://www.mosquitoresults.com/. In order to protect patient confidentiality, only limited information is 
released on any individual. MDPH generally releases only age category, gender, current patient status, 
county of residence and likely exposure location, if known. This website, which also includes links to a 
variety of educational materials related to mosquito-borne diseases, is updated on a daily basis 
throughout the arbovirus season. Results are also reported to the CDC’s ArboNET reporting system.  
 
MDPH usually issues public health alerts through the media when surveillance information 
indicates an increased risk of human disease or if a significant surveillance event occurs (for 
example, the first arbovirus activity of the season). In general, alerts include current surveillance 
information and emphasize prevention strategies. 
 
VII. PREVENTION AND RESPONSE: RECOMMENDATIONS FOR PHASED RESPONSE TO 
SURVEILLANCE DATA 
 
The guidance provided here is based on current knowledge of risk for human disease, and 
appropriateness and efficacy of interventions available to reduce that risk. Multiple factors 
contribute to the risk for mosquito-transmitted human disease. Decisions about risk reduction 
measures should be made after consideration of surveillance information.  
 
Public awareness of what can be done to reduce risk of infection is of utmost importance. Typically, risk 
for any individual is expected to be relatively low, and the routine precautions taken by individuals may be 
sufficient to reduce opportunities for infection. Routine precautions should include: 
 avoiding outdoor activity in areas, and during times of day, with increased mosquito activity;  
 use of mosquito repellents containing an EPA registered active ingredient; and 
 use of clothing to reduce mosquito access to skin. 
 
These personal protective measures must form the basis of all risk reduction and the need to utilize them 
is not reduced by any mosquito control activities, including aerial spraying. When multiple factors that 
indicate an increased risk for transmission to humans are present, additional risk reduction measures may 
be necessary. These guidelines take into consideration the complexity of reducing risk of human disease 
from EEE and WNV infection, and form a framework for decision-making by both individuals and 
agencies.  
 
General guidelines are provided for an array of situations as noted in the Surveillance and Response Plan 
tables that follow. Specific situations must be evaluated individually and options discussed before actions 
are taken. Estimating risk from mosquito-borne disease(s) is complex and many factors modify specific 
risk factors. MDPH assesses risk and works with LBOH, MCPs, and the SRMCB to develop the most 
appropriate response activities to reduce the risk of human disease. There is no single indicator that can 
provide a precise measure of risk, and no single action that can completely ensure prevention of infection. 
 
MDPH works collaboratively with other state agencies, the SRMCB and MCPs to collectively identify and 
support the use of safe and effective mosquito control measures based on integrated pest management 
(IPM) principles.  
 
Risk for mosquito-borne disease is virtually eliminated by the first local hard frost which kills 
most remaining adult mosquitoes. Since Culex species, which spread WNV, find warm, protected 
areas to survive the winter, isolated cases of WNV may rarely occur even after a hard frost.  
 
A hard, or killing frost, is defined meteorologically as two consecutive hours of temperatures below 28 
degrees Fahrenheit or three hours below 32 degrees. This will occur at different times for different 
communities, and there may even be variation within communities based on local geography. MDPH 
does not have meteorologic data or expertise and cannot determine when individual communities have 
experienced a hard frost. Sources of information to assist local officials with determining when a hard 
frost has occurred can be found on the weather reports from local media outlets, through the National 
Weather Service (http://w2.weather.gov/climate/) and other online resources such as Weather 
Underground (https://www.wunderground.com/). Community officials may be aware of additional local 
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resources that are available. Although mosquitoes are not killed until a hard frost occurs, they are 
extremely unlikely to be active when temperatures fall below 50 degrees in the evening, and communities 
may wish to consider this information when making decisions about scheduling or cancelling planned 
outdoor events late in the season. 
 
Criteria for re-evaluating late season risk in communities that reached high or critical levels of risk from 
EEE are not clearly defined.  MDPH is working with mosquito and disease experts to assess whether or 
not surveillance and/or temperature data can be used to accurately predict declining risk, toward the end 
of the mosquito season and prior to the occurrence of a hard frost. Multiple challenges to this exist 
including potentially increasing infection rates among surviving late-season mosquitoes, yet decreasing 
trapping success as evenings cool. This limits data available to assess accurate mosquito abundance 
and infection rates.  Any actionable information will be released as an addendum to the plan. 
 
A. MDPH Guidance  
 
Human cases of WNV and EEE occur primarily in August and September although the specific timing of 
the peak disease transmission season is affected by mosquito populations, level of virus activity and 
weather conditions (Figure 4). 
 
MDPH uses data from arbovirus surveillance to assess human risk levels as outlined in the phased 
response tables of this plan. Risk levels are defined for "focal areas". Focal areas frequently, but not 
always, incorporate multiple communities, towns, or cities. Factors considered in the assessment 
of human risk and the outlining of a particular focal area include: mosquito habitat, virus 
isolations in surveillance specimens from previous years, human population densities, type and 
timing of recent isolations of virus in mosquitoes, occurrence of human case(s) in the current or 
previous years, current and predicted weather patterns, and seasonality of conditions needed to 
present risk of human disease. In general, focal areas are likely to include the municipality with the 
positive finding and at least all adjacent communities. In general, assignment of risk will involve identifying 
the highest risk communities and then setting surrounding communities at the next highest risk level. For 
example, when evidence exists that a focal area is at high risk for EEE, in most cases, all adjacent 
communities will be set at moderate. Geographic areas commonly associated with human cases will have 
larger focal areas than those without a repeated history of human cases. 
 
Prolonged heat promotes risk from both WNV and EEE by increasing the rate of mosquito reproduction 
and development, as well as decreasing the amount of time it takes for an infected mosquito to become 
able to transmit the virus. Weather conditions favorable for development of elevated WNV risk include 
hot, generally dry weather with rain occurring as downpours rather than light precipitation. Weather 
conditions favorable for development of elevated EEE risk include increased rainfall in the preceding fall 
and/or spring and mild winters or those with insulating snow cover. Evidence for elevated risk is also 
indicated by EEE activity in the preceding year, isolation of virus from a mammal-biting species of 
mosquito and isolations of the virus before mid-July. 
 
Although mosquito surveillance data will be reported to local jurisdictions as it becomes available, in 
general, risk assessments that result in changes of low to moderate levels in communities are conducted 
twice per week, on Mondays and Thursdays. This streamlines communication and improves the ability of 
the MCPs to plan and schedule response activities. An exception to this schedule will be when 
information is obtained that indicates a community should be moved from moderate to high risk because 
of the need for timely consideration of  recommended response activities. Additional exceptions to this 
protocol may be made as dictated by rapidly evolving situations. 
 
B. Risk Reduction and Prevention Guidance for Seasons with Indicators of Increased EEE Risk 
 
Based on historical experience with EEE, MDPH has identified specific critical indicators for overall EEE, 
risk, and provides specific risk reduction and prevention guidance for seasons with an anticipated 
increased EEE risk. Activities that may be undertaken in response to indicators of increased risk include: 
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 MDPH may release public health alerts throughout the season to remind the public of the steps to 
take to reduce their risk of exposure to mosquitoes. Local boards of health are encouraged to conduct 
their own outreach which should include information about personal prevention measures such as: 
avoiding outdoor activity during times of day, with increased mosquito activity; use of mosquito 
repellents containing an EPA-approved active ingredient; and use of clothing to reduce mosquito 
access to skin. These personal protective measures must form the basis of all risk reduction and the 
need to utilize them is not reduced by any mosquito control activities, including aerial spraying. 
 Local municipalities may be encouraged to reschedule outdoor evening events to avoid the period 
between dusk and dawn which correspond to peak mosquito activity. 
 For communities that participate in a local mosquito control district, MCPs may increase their source 
reduction activities to reduce mosquito-breeding habitats and to reduce adult mosquito abundance. 
This may include ground and aerial larviciding. 
 For communities that participate in a local mosquito control district, after sustained findings of positive 
mosquito isolates, adult mosquito control efforts including targeted ground adulticiding operations 
should be considered, if not already in progress, where surveillance indicates human risk. The 
decision to use ground-based adult mosquito vector control will depend on critical modifying variables 
including the time of year, mosquito population abundance, and proximity of virus activity to 
populations.  
 Other intensified efforts may be implemented following coordination between MDPH and other 
agencies including DEP, DAR, and DCR. 
 If the risk for multiple human infections with EEE virus becomes widespread and involves multiple 
jurisdictions, MDPH will convene the SRMCB, MCPs, and MAG to get their recommendation for 
appropriate mosquito control interventions to reduce public health risk. The SRMCB will provide 
recommendations on appropriate pesticide(s), route(s), and means of treatment for specific areas. 
Interventions may include state-funded aerial application of mosquito adulticide. Assessment of the 
need for and utility of a focal or large-scale aerial application of mosquito adulticide includes 
evaluating evidence that the seasonal and biological conditions present a persistent risk of human 
disease, and that those same conditions permit the effective use of an aerially applied pesticide. 
Aerial applications cannot and do not eliminate risk and must not be viewed by the public or 
municipalities as a solution to EEE risk; aerial applications are one tool that can be used in 
conjunction with all other available risk mitigation tools. 
 
VIII. EMERGING ARBOVIRUS ISSUES 
 
A. Expanding EEE Virus Habitat  
 
As indicated by virus activity surveillance, the geographic area of risk for EEE has increased outside the 
historical areas of southeastern Massachusetts. Human and animal cases have occurred in Essex, 
Franklin and Hampshire counties. EEE risk has also increased throughout New England; New 
Hampshire, Maine and Vermont have all detected unusual activity. Based on the surveillance data 
tracked by MDPH, there are communities outside of the Southeastern Region of the state that either do 
not belong to an established MCP, or do not have an MCP operating in their region, that are now at 
increased risk for EEE virus activity.  Expansion of the current mosquito virus surveillance network is 
required to provide adequate surveillance data to assess the public’s risk for arboviral diseases.  
 
B. Introduced Mosquito Species 
 
MDPH and the MCPs are taking proactive measures to conduct surveillance for mosquito species that are 
expanding northward, especially Aedes albopictus. Ae. albopictus is an aggressive mammal-biting 
species that was introduced to North America from Asia around 1985; it has been implicated in the 
transmission of arboviruses such as dengue, chikungunya, yellow fever, and Zika, where these viruses 
circulate. Where it occurs, this species is generally more abundant in urban areas, breeding easily in 
artificial containers, such as birdbaths, discarded tires, buckets, clogged gutters, catch basins, and other 
standing water sources. These mosquitoes are aggressive biters that actively seek out mammals, 
including humans, including during daytime hours, unlike the more familiar mosquito vectors for WNV 
and EEE. The adult mosquitoes are black with distinctive white stripes on their legs and thorax and are 
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sometimes referred to as “Asian tiger mosquitoes”. While Ae. albopictus has displaced native mosquito 
species across the southern US, its establishment in northern latitudes has been limited to date.  
 
The range of Ae. albopictus is expanding into the Northeast likely due to changes in the climate and 
based on new surveillance data, there is evidence that focal Ae. albopictus populations can over-winter, 
particularly during mild winters or in protected environments such as tire piles, in Massachusetts. 
Surveillance specifically targeting the adult stage of this species in Massachusetts began in 2008. 
Beginning in 2014, MDPH and the MCP’s began a more coordinated effort to systematically survey for 
the presence of Ae. albopictus in MA. This survey centers on areas and activities known to correlate with 
Ae. albopictus introduction in other states. The targeted areas are closely monitored using traps 
specifically designed to capture both adult Ae. albopictus and their eggs. Adult Ae. albopictus are 
identifiable based on their distinctive appearance; eggs must be allowed to develop into the adult stage in 
captivity in order to identify the species. Surveillance for this invasive species of mosquito is critically 
important at this time and requires the continued collaboration and cooperation of all MCPs and MDPH. 
 
Because these mosquitoes almost exclusively feed on mammals and not the bird species that serve as 
reservoirs for WNV and EEE, these mosquitoes are not expected to play a significant role in spreading 
either WNV or EEE. However, if large populations of this mosquito species become established in 
Massachusetts over time, as has been suggested may happen with changes in climate, it could 
eventually serve as a vector for other arboviruses that do not currently circulate in the area. See Table 3 
for recommendations related to a phased response for surveillance and response to Ae. albopictus and 
Figure 5 for a map of communities with any finding of Aedes albopictus since 2009.  
 
Control of Ae. albopictus is difficult once it is established although its flight range is quite limited at 
approximately 150 yards. Commonly used larval control measures include: environmental sanitation 
focused on the permanent elimination of containers producing Ae. albopictus; chemicals or biological 
agents used as larvacides to kill or prevent development of mosquito immature stages; and biological 
control which relies on aquatic predators. Both larvaciding and biological control measures are limited in 
efficacy due to the preference of this species for breeding in small containers. Identification and removal 
of non-essential containers (e.g. refuse and tires) and reduction and regular cleaning of useful containers 
(e.g. toys, bird baths, and gutters) are critical to reduce breeding sites and therefore mosquito 
populations. Because this species is most active during the day, mosquito control techniques employed 
during the dusk to dawn hours when local vector mosquito species are most active, will be less effective. 
The use of personal precautions such as avoiding outdoor activity in areas with increased mosquito 
activity, use of mosquito repellents containing an EPA registered active ingredient, and use of clothing to 
reduce mosquito access to skin must form the basis of all risk reduction, as they do for all mosquito-borne 
diseases. 
 
Any identifications of Ae. albopictus will be reported to the LBOH and MCP by telephone and will be 
shared with the SRMCB and MAG by email. MDPH will work with the MCP, if there is one, to perform any 
necessary enhanced surveillance. Simply identifying the presence of the species in a particular area is 
not evidence of any immediate public health risk.  
 
In the extremely unlikely event that a human case of dengue, chikungunya, Zika, yellow fever, or other 
non-endemic arbovirus is reported, and patient history does not include out-of-region travel, then 
surveillance for and testing of Ae. albopictus may be indicated in the area. If any virus of public health 
importance is identified from Ae. albopictus mosquitoes, both mosquito control and public health 
intervention measures may be necessary. Appropriate responses will be determined in collaborative 
efforts between state and local health and the Mosquito Control Projects.  
 
Aedes aegypti, another important vector species for arboviral diseases, has been reported as far north as 
New York state, and its range may also be expanding northward; however, it has not been detected in 
Massachusetts.  MDPH and MCPs will continue to be vigilant for the appearance of this, or any other 
invasive mosquito vector species. 
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C. Introduced or Emerging Arboviral Diseases 
 
MDPH is continuing to work with its partner agencies to monitor for emerging arboviral diseases.  Every 
year, some Massachusetts residents traveling abroad, become infected with mosquito-borne diseases 
such as dengue, malaria, chikungunya and Zika. Given the species of mosquitoes that are currently found 
in Massachusetts, it is very unlikely that these diseases will become established at this time. 
 
However, the diagnosis of any arboviral disease in Massachusetts residents is reportable to the LBOH 
and MDPH (105 CMR 300.00: Reportable diseases, surveillance, and isolation and quarantine 
requirements | Mass.gov) and requires public health investigation. If an investigation indicates that the 
disease was acquired locally (i.e. NOT acquired through foreign travel), MDPH may test banked mosquito 
specimens for the presence of the virus and/or perform enhanced mosquito surveillance, alone or in 
conjunction with a local MCP, in order to assess the risk to public health. Specific surveillance and 
response activities will be situation dependent and will be determined drawing on the expertise of all 
partners. Specific public health risk messages will be developed, shared with local partners, and 
communicated to the public as indicated. 
 
In addition, MDPH, as part of its routine surveillance, has the potential to test a portion of trapped and 
submitted mosquitoes with a non-specific screening test which, if positive, would trigger more specific 
testing to detect an introduced or emerging disease.  
 
Testing for non-endemic arboviruses is not routinely performed at the Massachusetts State Public Health 
Laboratory. However, due to the recent emergence of Zika virus in Central and South America and the 
Caribbean, MDPH rapidly implemented human testing for dengue, chikungunya and Zika viruses. 
Developing the capacity to test for Jamestown Canyon in mosquitoes is being explored. Decisions to 
perform surveillance for any arboviral pathogen within local mosquitoes will be based on information 
indicating new or unusual activity and/or local environmental detection of mosquito vectors that could 
support new viral agents. This continues to be part of an ongoing risk assessment performed by MDPH 
and CDC’s Arbovirus Surveillance Network. 
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Aerial Adulticide Application in Response to Threat of EEE 
2019 Multi-Agency Response Flowchart 
 
 
1. Determination of Response  
 When human risk is elevated to a high level of concern as indicated by the MDPH Surveillance 
and Response Plan; DPH will determine, in consultation with Mosquito Control Projects, 
SRMCB, and the Mosquito Advisory Group whether aerial application is warranted.  
 
 
2. Characterization of Area of Risk 
 Once consensus is obtained, DPH characterizes the area of risk and delineates the perimeter of the 
spray area based on current surveillance information, habitat, areas of historical activity likely to 
contribute to current risk and known patterns of virus spread. 
 DPH/BIDLS provides the GIS perimeter map to inter-agency collaborators as soon as possible. 
 
 
3. Commissioner Certification 
 DPH/BIDLS requests that the Commissioner of Public Health issue a “Certification that 
Pesticide Application is Necessary to Protect Public Health”  
 
 
Action Items 4a-4c Occur Simultaneously: 
 
4a. Determination of Appropriate Pesticide 
 Prior to July 1 of each season, DPH/BEH and DAR will determine the type of pesticide to be 
used in the event that an aerial application will be warranted and obtain any EPA pesticide 
waivers, if necessary, for use in aerial application.  
 In the event that aerial application is warranted, DPH/BEH and DAR will confirm this selected 
pesticide for use. 
 
 
4b.Determination of No-Spray Zones 
 Aerial no-spray zones (mosquito treatment sensitive areas data layers) defined: 
1) Certified organic farms 
2) Priority habitats for federally listed  endangered and threatened  species  
3) Surface water supply resource areas 
4) Commercial fish hatcheries/aquaculture 
 DAR reviews any emergency waivers needed to use pesticides on school property and ensure 
compliance with pesticide laws.  
 DAR/SRMCB will submit a ‘Notice of Intent’ to EPA to obtain an NPDES permit within 30 
days of the aerial adulticide event. 
 
 
4c.Exclusion/Inclusion of Priority Habitats: 
 DPH will determine, in consultation with SRMCB, DAR, DEP, and DFW if spraying in 
mosquito treatment sensitive areas is necessary to protect the public health.  
 If spraying in these areas is necessary to reduce the risk to public health then: 
o DPH requests a permit from DFW be issued to DAR for taking endangered, threatened, 
or special concern species. 
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4d. Spray Efficacy Monitoring 
 DAR/SRMCB and MDPH initiates plans for standardized monitoring of pre- and post-spray 
mosquito activity as part of spray efficacy determination.  MDPH may assist DAR/SRMCB with 
GIS mapping 
 All agencies to follow procedures outlined in the SRMCB/Massachusetts Mosquito Control 
Surveillance Protocol for Evaluation of Efficacy of Aerial Adulticide Application Regarding 
Mosquito-Borne Disease(SRMCB Protocol, Appendix 3) 
 SRMCB provides a report of the intervention that includes percent efficacy results (SRMCB 
SOP, p.23 ‘Assess Operation’). 
 
 
5. Preparation of Final GIS Data Map  
 DAR coordinates compilation of mosquito treatment sensitive areas data layers (no-spray zones) 
developed by DAR, DFW, and DEP within designated DPH spray area into a final map. 
 
 
6. Environmental Monitoring 
 DEP, DAR, DFG and DPH/BEH notify partner environmental agency collaborators of planned 
environmental monitoring to provide opportunity for input/collaboration.  
 DEP, DAR, and DPH/BEH and BIDLS initiate plans for pre-/post-monitoring for public drinking 
water reservoirs, honeybees, surface waters, and cranberries in designated spray area. 
 
 
7. Emergency Room and Poison Control Contacts 
 DPH/BEH contacts and provides pesticide illness surveillance protocols to emergency 
departments, poison control centers, and local health departments. 
 
 
8. Notification of Date & Time of Application 
 DAR and DPH provide public notices regarding the locations, dates, and times of aerial spraying. 
 DAR will maintain a website with GIS maps of the aerial spray area and will update this site 
daily during spray operations. 
 DPH will provide recorded hotline information regarding the spray zone, precautionary 
measures, and telephone numbers to report fish kills or other environmental impacts. 
 
 
9. Operational Procedures-Aerial Application 
 DAR/SRMCB initiates aerial spray operations using collective guidance and consensus 
developed through multi-agency, cross-secretariat process.  
 The aerial application operational procedures are followed as described in the SRMCB 
Operational Response Plan. 
 
 
 
DPH- Department of Public Health 
BIDLS- Bureau of Infectious Disease and Laboratory Sciences 
BEH- Bureau of Environmental Health 
 
 
DAR- Department of Agricultural Resources 
SRMCB- State Reclamation and Mosquito Control Board 
DFG- Department of Fish and Game 
DFW- Division of Fisheries and Wildlife  
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Table 1.  Guidelines for Phased Response to WNV Surveillance Data  
 
Risk 
Category 
Probability of 
locally acquired 
human disease 
Definition of Risk Category for a Focal Area1 
 
Recommended Response  
1 WNV – Low All localities begin the year at low 
 
Current Year 
1. No evidence of WNV activity in mosquitoes in 
the focal area  
 
OR 
 
1. Sporadic WNV activity in mosquitoes in the 
focal area.  
 
And 
 
2. No animal or human cases  
 
Definitions: 
Sporadic WNV activity- when 1-2 mosquito 
isolates are detected during non-consecutive 
weeks within one focal area. 
 
Sustained WNV activity- when mosquito 
isolates are detected for at least 2 consecutive 
weeks within one focal area. (NOTE:  Two 
consecutive weekly findings from the same trap 
location may not always be considered 
indicative of sustained activity) .  
 
 
 
1. MDPH staff provides educational materials and 
clinical specimen submission protocols to targeted 
groups involved in arbovirus surveillance, including, 
but not limited to, local boards of health, physicians, 
veterinarians, animal control officers, and stable 
owners. 
 
2. Educational efforts directed to the general public on 
personal prevention steps and source reduction, 
particularly to those populations at higher risk for 
severe disease (e.g., the elderly). 
 
3. Passive human and horse surveillance. 
 
4. Public health alert sent out by MDPH in response to 
first WNV virus positive mosquito pool detected during 
the season. The alert will summarize current 
surveillance information and emphasize personal 
prevention strategies. 
 
5.  Emphasize the need for schools to comply with MA 
requirements for filing outdoor IPM plans. 
 
For  localities participating in local mosquito control 
projects: 
6. Assess mosquito populations, monitor larval and 
adult mosquito density.  
 
7. Routine collection and testing of mosquitoes. 
 
8. Initiate source reduction; use larvicides at specific 
sites identified by entomologic survey. In making a 
decision to use larvicide consider the abundance of 
Culex larvae, intensity of prior virus activity and 
weather. 
 
9.  Locally determined, standard, adult mosquito 
vector control activities are implemented.  No specific 
supplemental control efforts are recommended. 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
1 Focal Area- May incorporate multiple communities, towns or cities. Factors considered in the assessment of 
human risk and the outlining of a particular focal area include: mosquito habitat, prior virus isolations in 
surveillance specimens from previous years, human population densities, type and timing of recent isolations of 
virus in mosquitoes, occurrence of human case(s) in the current or previous years, current and predicted weather 
patterns, and seasonality of conditions needed to present risk of human disease. 
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2 WNV - Moderate Current Year 
1. Sustained or increasing WNV activity in 
mosquitoes in the focal area.  
 
OR 
 
2. One confirmed animal or human case  
 
 
 
 
 
 
 
 
 
 
 
 
Definitions: 
Sporadic WNV activity- when 1-2 mosquito 
isolates are detected during non-consecutive 
weeks within one focal area. 
 
Sustained WNV activity- when mosquito 
isolates are detected for at least 2 consecutive 
weeks within one focal area. (NOTE:  Two 
consecutive weekly findings from the same trap 
location may not always be considered 
indicative of sustained activity)  
 
 
Response as in category 1, plus:  
  
1. Expand community outreach and public education 
programs, particularly among high-risk populations, 
focused on risk potential and personal protection, 
emphasizing source reduction.   
 
2. Local boards of health are contacted via phone or 
HHAN (Health and Homeland Alert Network) upon 
confirmation of WNV in any specimen. Advise health 
care facilities of increased risk status and 
corresponding need to send specimens to the MA 
SPHL for testing. 
3. Supplemental mosquito trapping and testing may 
be performed in areas with positive WNV findings.  
 
For  localities participating in local mosquito control 
projects:  
4. Increase larval control and source reduction 
measures. 
 
5. If not already in progress, standard, locally 
determined adult mosquito vector control efforts 
including targeted ground adulticiding operations 
should be considered against Culex mosquitoes and 
other potential vectors, as appropriate. The decision 
to use ground-based adult mosquito control will 
depend on critical modifying variables including the 
time of year, mosquito population abundance and 
proximity of virus activity to populations.  
 
3 WNV – High Current year                                            
1. Multiple isolations during the same week from 
the focal area plus at least one multiple 
meteorological or ecological conditions (such as 
above average temperatures, dry conditions, or 
larval abundance) associated with increased 
abundance and increased risk of human 
disease.    
 
 
Or 
 
2. Two or more confirmed animal or human 
cases of WNV occurring within the focal area 
(focal area based on exposure history of cases)                                                               
 
Response as in category 2, plus: 
1. Intensify public education on personal protection 
measures including avoiding outdoor activity during 
peak mosquito hours, wearing appropriate clothing, 
using repellents and source reduction. 
a. Utilize multimedia messages including public health 
alerts from MDPH, press releases from local boards 
of health, local newspaper articles, cable channel 
interviews, etc. 
b.  Encourage local boards of health to actively seek 
out high-risk populations in their communities (nursing 
homes, etc.) and educate them on personal protection 
and avoiding outdoor evening events.  
c. Advisory information on pesticides provided by 
MDPH Bureau of Environmental Health.                                                                     
 
2. Intensify and expand active surveillance for human 
cases. 
 
 For  localities participating in local mosquito control 
projects:  
3. Intensify larviciding and/or adulticiding control 
measures where surveillance indicates human risk. 
Local, ground- based ULV applications of adulticide 
may be repeated as necessary to achieve adequate 
mosquito control.  
 
4. Duly authorized local officials may request that the 
DPH Commissioner issue a certification that pesticide 
application is necessary to protect public health in 
order to preempt homeowner private property no-
spray requests. 
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4 WNV - Critical An excessive number of human cases clustered 
in time and space AND evidence that risk is 
likely to increase based on time of year, 
weather patterns, mosquito populations or other 
factors specific to the situation. 
Response as in category 4, plus: 
 
1. MDPH will confer with local boards of health, the 
SRMCB and Mosquito Control Projects to discuss the 
need for additional interventions. 
 
If additional mosquito control activities are indicated, 
the SRMCB will determine the appropriate pesticide 
and extent, route and means of treatment. 
 
2. MDPH recommends reduction of outdoor activities, 
during peak mosquito activity hours, especially by the 
elderly and others at higher risk for severe WNV 
disease, in areas of intensive virus activity for high 
risk populations or individuals. 
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 Table 2.  Guidelines for Phased Response to EEE Surveillance Data 
 
Risk 
Category 
Probability of 
locally acquired 
human disease 
Definition of Risk Category for a Focal Area2 
 Recommended Response 
1 EEE - Remote All of the following conditions must be met: 
Prior Year 
No EEE activity detected in community or focal 
area in at least 10 years 
 
And 
Current Year 
1. No current surveillance findings indicating 
EEE activity in mosquitoes in the focal area                   
 
And 
2. No confirmed animal or human EEE cases. 
 
 
1. MDPH staff provides educational materials and 
clinical specimen submission protocols to targeted 
groups involved in arbovirus surveillance, including, 
but not limited to, local boards of health, physicians, 
veterinarians, animal control officers, and stable 
owners. 
 
2. Educational efforts directed to the general public 
on personal prevention steps and source reduction, 
particularly to those populations at higher risk for 
severe disease (e.g., children and the elderly). 
 
3. Passive human and horse surveillance. 
 
4. Public health alert sent out by MDPH in response 
to first EEE virus positive mosquito pool detected 
during the season. The alert will summarize current 
surveillance information and emphasize personal 
prevention strategies. 
 
5.  Emphasize the need for schools to comply with 
MA requirements for filing outdoor IPM plans. 
 
For  localities participating in local mosquito control 
projects: 
6. Assess mosquito populations, monitor larval and 
adult mosquito density.  
 
7. Routine collection and testing of mosquitoes. 
 
8. Initiate source reduction; use larvicides at 
specific sites identified by entomologic survey. In 
making a decision to use larvicide consider the 
abundance of Culex larvae, intensity of prior virus 
activity and weather. 
 
9.  Locally determined, standard, adult mosquito 
vector control activities are implemented.  No 
specific supplemental control efforts are 
recommended. 
 
 
 
 
 
 
                                                 
2 Focal Area- May incorporate multiple communities, towns or cities. Factors considered in the assessment of 
human risk and the outlining of a particular focal area include: mosquito habitat, prior virus isolations in 
surveillance specimens from previous years, human population densities, type and timing of recent isolations of 
virus in mosquitoes, occurrence of human case(s) in the current or previous years, current and predicted weather 
patterns, and seasonality of conditions needed to present risk of human disease. 
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2 EEE - Low Prior Year 
Any EEE activity detected within the last 10 
years 
 
Or 
 
Current Year 
1. Sporadic EEE isolations in  Cs. melanura 
mosquito in the community or focal area  
 
And 
 
2. No confirmed animal or human cases. 
 
Definitions: 
Sporadic EEE activity- when 1-2 mosquito 
isolates are detected during non-consecutive 
weeks within one focal area. 
 
Sustained EEE activity- when mosquito 
isolates are detected for 2 or more consecutive 
weeks within one focal area.  
 
Response as in category 1, plus:  
  
1. Expand community outreach and public 
education programs, particularly among high-risk 
populations, focused on risk potential and personal 
protection, emphasizing source reduction.   
 
For localities participating in local mosquito control 
projects: 
2. Increase larval control and source reduction 
measures. 
 
3. Locally established standard adult mosquito 
vector control activities continue. 
 
 
 
3 EEE - Moderate Prior Year                                                                                                                           
Sustained EEE activity in bird-biting 
mosquitoes; or EEE isolate from mammal-biting 
mosquitoes; or confirmation of one human or 
animal EEE case in the community or focal 
area 
 
Or 
  
Current year                                                                                             
1. Sustained EEE activity in Cs. melanura  with 
minimum infection rates that are at or below 
mean levels for focal area trap sites  
                      
 Or 
2. A single EEE isolate from mammal-biting  
mosquitoes (bridge vector species) 
 
Or 
 
3. Sustained EEE activity plus at least one 
multiple meteorological or ecological condition 
(rainfall, temperature, seasonal conditions, or 
larval abundance) associated with elevated 
mosquito abundance and thus likely to increase 
the risk of human disease 
 
AND 
 
4. No confirmed animal or human EEE cases in 
current year 
 
   
Response as in category 2, plus: 
 
1. Outreach and public health educational efforts 
are intensified including media alerts as needed. 
 
2. Public health alert sent out by MDPH in response 
to first pool of EEE positive mammal-biting 
mosquitoes detected during the season.  The alert 
will summarize current surveillance information and 
emphasize personal prevention strategies. 
 
3. HHAN (Health and Homeland Alert Network) 
alerts or phone calls are provided to local boards of 
health upon confirmation of EEE in any specimen; 
advise health care facilities of increased risk status 
and corresponding needs to send specimens to the 
MA SPHL for testing. 
 
4. Supplemental mosquito trapping and testing in 
areas with positive EEE findings if MDPH resources 
allow.  Notify all boards of health of positive 
findings.   
 
 
For localities participating in local mosquito control 
projects: 
5. If not already in progress, standard, locally 
established adult mosquito vector control efforts 
including targeted ground adulticiding operations 
should be considered where surveillance indicates 
human risk. The decision to use ground-based adult 
mosquito control will depend on critical modifying 
variables including the time of year, mosquito 
population abundance and proximity of virus activity 
to at-risk populations.  
 
6. Duly authorized local officials may request that 
the DPH Commissioner issue a certification that 
pesticide application is necessary to protect public 
health in order to preempt homeowner private 
property no-spray requests. 
 
7. Supplemental mosquito trapping and testing in 
areas with positive EEE findings.  Notify all boards 
of health of positive findings.   
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4 EEE - High Current Year 
1. Sustained or increasing EEE activity in Cs. 
melanura with weekly mosquito minimum 
infection rates above the mean,  
 
Or 
 
2. 2 or more EEE isolates in mammal-biting 
mosquitoes from 2 different traps. 
 
And/or 
 
3. Sustained or increasing EEE activity in 
mosquitoes plus multiple meteorological or 
ecological conditions (rainfall, temperature, 
seasonal conditions, or larval abundance) 
associated with elevated mosquito abundance 
and thus very likely to increase the risk of 
human disease.  
 
 AND 
 
4. No confirmed animal or human EEE cases in 
current year 
 
Response as in category 3, plus:  
 
1. Intensify public education on personal protection 
measures including avoiding outdoor activity during 
peak mosquito hours, wearing appropriate clothing, 
using repellents and source reduction. 
a. Utilize multimedia messages including public 
health alerts from MDPH, press releases from local 
boards of health, local newspaper articles, cable 
channel interviews, etc. 
b.  Encourage local boards of health to actively 
seek out high-risk populations in their communities 
(nursing homes, schools, workers employed in 
outdoor occupations, etc.) and educate them on 
personal protection  
c.  Advisory information on pesticides provided by 
MDPH Bureau of Environmental Health.                                                                    
d. Urge towns and schools to consider rescheduling 
outdoor, evening events.† 
   
2. For localities participating in local mosquito 
control projects, intensify larviciding and/or 
adulticiding control measures where surveillance 
indicates human risk. Local, ground- based ULV 
applications of adulticide may be repeated as 
necessary to achieve adequate mosquito vector 
control. Duly authorized local officials may request 
that the DPH Commissioner issue a certification 
that pesticide application is necessary to protect 
public health in order to preempt homeowner 
private property no-spray requests. 
 
3.  Active surveillance for human cases is 
intensified. Health care facilities are advised of 
increased risk status and corresponding needs to 
send specimens to the MA SPHL for testing. 
4. Local officials should evaluate all quantitative 
indicators including population density and time of 
year and may proceed with focal area aerial 
adulticiding. 
 
5. MDPH will confer with local health officials, 
SRMCB and MCPs to determine if the risk of 
disease transmission warrants classification as 
level 5. 
6. MDPH will confer with local health agencies, 
SRMCB and Mosquito Control Projects to discuss 
the use of intensive mosquito control methods. If 
elevated risk is assessed in multiple jurisdictions 
and evidence exists that risk is likely to either 
increase (based on time of season, weather 
patterns, etc.) or remain persistently elevated, the 
interventions may include state-funded aerial 
application of mosquito adulticide which, if 
conditions warrant, may be repeated as necessary 
to interrupt the virus transmission cycle and protect 
public health. 
 
 
 
 
† See Appendix 2 for schedule of recommended cancellation time for use 
during 2012 season 
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5 EEE - Critical Current Year 
 
1.  Multiple quantitative measures indicating 
critical risk of human infection (e.g. early 
season positive surveillance indicators, and 
sustained  high mosquito infection rates, plus 
multiple meteorological or ecological conditions 
(rainfall, temperature, seasonal conditions, or 
larval abundance)  indicating rapidly escalating 
epizootic activity)   
 
Or 
 
2. A single confirmed EEE human or animal 
case 
 
 
 
 
  
Response as in category 4, plus: 
1. Continued highly intensified public outreach 
messages on personal protective measures. 
Frequent media updates and intensified community 
level education an outreach efforts. Strong 
recommendation for rescheduling of outdoor, 
evening events.† 
2. MDPH will confer with local health agencies, 
SRMCB and Mosquito Control Projects to discuss 
the use of intensive mosquito control methods and 
determine the measures needed to be taken by the 
agencies to allow for and assure that the most 
appropriate mosquito control interventions are 
applied to reduce risk of human infection. These 
interventions may include state-funded aerial 
application of mosquito adulticide. 
 
Factors to be considered in making this decision 
include the seasonal and biological conditions 
needed to present a continuing high risk of EEE 
human disease and that those same conditions 
permit the effective use of an aerially applied 
pesticide. 
 
Once critical human risk has been identified, the 
SRMCB will determine the adulticide activities that 
should be implemented in response to identified risk 
by making recommendations on: 
 
A. Appropriate pesticide 
B. Extent, route and means of treatment 
C. Targeted treatment areas  
  
3. MDPH Bureau of Environmental Health will 
initiate active surveillance for pesticide-related 
illness via emergency departments and with health 
care providers only if aerial spraying commences. 
 
4.  MDPH will designate high-risk areas where 
individual no spray requests may be preempted by 
local and state officials based on this risk level.  If 
this becomes necessary, notification will be given to 
the public.  
 
5. MDPH recommends restriction of group outdoor 
activities, during peak mosquito activity hours, in 
areas of intensive virus activity. 
 
6. MDPH will communicate with health care 
providers in the affected area regarding surveillance 
findings and encourage prompt sample submission 
from all clinically suspect cases. 
 
 
 
 
 
 
 
 
 
 
 
† See Appendix 2 for schedule of recommended cancellation time for use during 2019 season 
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Table 3.  Guidelines for Phased Response to Aedes albopictus  
 
 
Risk 
Category 
 
Definition of Risk Category 
 
Recommended Response 
1 No identification of Aedes albopictus 
activity in a given area 
-MDPH, SRMCB and MCDs identify areas proven to serve as routes 
of entry for A. albopictus (examples: shipping ports, tire recyclers, 
etc.) 
-Coordinate surveillance in these areas 
2 Isolated or intermittent identification in a 
given area  of adult Aedes albopictus  
likely to represent introduction or repeated 
reintroductions 
-Continue or expand surveillance 
-Submit any adult mosquitoes for storage and possible testing at the 
MA SPHL as the situation warrants 
-Work with LBOH to identify possible habitat/potential breeding sites 
and initiate clean-up as necessary 
3 Consistent findings of adult Aedes 
albopictus or evidence of  possible 
overwintering 
-Submit  any adult mosquitoes for storage and possible testing at the 
MA SPHL as the situation warrants 
-Expand surveillance to detect extent of geographic distribution 
-Work with LBOH to identify possible habitat/potential breeding sites 
and initiate clean-up 
- Educational efforts directed to the general public on personal 
prevention steps and source reduction 
-DPH consultation with MCDs, SRMCB, and MAG to assess and 
evaluate the need for larvaciding or adulticiding interventions 
 
 
Figure 1: County of Residence of West Nile Virus Human Cases, 2000-2018 
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Figure 2: Municipality of Residence of West Nile Virus Human Cases, 2001-2018 
 
 
Figure 3:  Location of MDPH Long-Term Mosquito Trap Sites 
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Figure 4: Month of Symptom Onset of WNV and EEE Human Cases in 
Massachusetts, 2001-2018.  
 
 
 
Figure 5:  Location of Aedes albopictus collections, 2009-2018
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Appendix 1:  Mosquitoes Associated with Arboviral Activity in Massachusetts 
 
Aedes vexans – Is a common nuisance mosquito. Temporary flooded areas such as woodland pools and 
natural depressions are the preferred larval habitat of this mosquito. It feeds on mammals and is an 
aggressive human biter. This species is typically collected from May to October. Ae vexans is an epizootic 
(bridge) vector of eastern equine encephalitis (EEE) virus. 
 
Coquillettidia perturbans - Cattail marshes are the primary larval habitat of this mosquito. It feeds on 
both birds and mammals. It is a persistent human biter and one of the most common mosquitoes in 
Massachusetts. This species is typically collected from June to September. Cq perturbans is an epizootic 
(bridge) vector of EEE virus. 
 
Culex pipiens – Artificial containers are the preferred larval habitat of this mosquito. It feeds mainly on 
birds and occasionally on mammals. It will bite humans, typically from dusk into the evening. This species 
is regularly collected from May to October but can be found year round as it readily overwinters in man-
made structures. Cx pipiens is the primary vector of West Nile Virus (WNV). 
 
Culex restuans – Natural and artificial containers are the preferred larval habitat of this mosquito. It 
feeds almost primarily on birds but has been known to bite humans on occasion. This species is typically 
collected from May to October but can be found year round as it readily overwinters in man-made 
structures.  Cx restuans has been implicated as a vector of WNV.   
 
Culex salinarius – Brackish and freshwater wetlands are the preferred habitat of this mosquito. It feeds 
on birds, mammals, and amphibians and is well known for biting humans. This species is typically 
collected from May to October but can be found year round as it readily overwinters in natural and man-
made structures. Cx salinarius may be involved in the transmission of both WNV and EEE.   
 
Culiseta melanura –White cedar and red maple swamps are the preferred larval habitat of this mosquito. 
It feeds almost exclusively on birds. This species is typically collected from May to October. Cs melanura 
is the primary enzootic vector of EEE.  
 
Ochlerotatus canadensis – Shaded woodland pools are the preferred larval habitat of this mosquito. It 
feeds mainly on birds and mammals but is also known to take blood meals from amphibians and reptiles. 
This mosquito can be a fierce human biter near its larval habitat. This species is typically collected from 
May to October. Oc canadensis is an epizootic (bridge) vector of eastern equine encephalitis EEE virus. 
 
Ochlerotatus japonicus – Natural and artificial containers such as tires, catch basins, and rock pools are 
the preferred larval habitat of this mosquito. It feeds mainly on mammals and is an aggressive human 
biter. This species is typically collected from May to October. Oc japonicus may be involved in the 
transmission of both WNV and EEE. 
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APPENDIX 2: RECOMMENDED CANCELLATION TIMES FOR OUTDOOR ACTIVITIES IN 
AREAS OF HIGH RISK FOR EASTERN EQUINE ENCEPHALITIS (EEE) 
The types of mosquitoes most likely to transmit EEE infection are 
likely to be out searching for food (an animal to bite) at dusk, the time 
period between when the sun sets and it gets completely dark. The 
exact timing of this increased activity is influenced by many factors 
including temperature, cloud cover, wind and precipitation and 
cannot be predicted precisely for any given day. Here, the 
approximate time of sunset was used to establish standardized 
recommendations for cancellation times of outdoor activities during 
periods of high EEE risk.  
 
This does not eliminate risk nor does it alleviate the need for 
the use of repellants or clothing for protection from 
mosquitoes. 
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APPENDIX 2: RECOMMENDED CANCELLATION TIMES FOR OUTDOOR ACTIVITIES IN 
AREAS OF HIGH RISK FOR EASTERN EQUINE ENCEPHALITIS (EEE) 
 
The types of mosquitoes most likely to transmit EEE infection are 
likely to be out searching for food (an animal to bite) at dusk, the 
time period between when the sun sets and it gets completely 
dark. The exact timing of this increased activity is influenced 
by many factors including temperature, cloud cover, wind 
and precipitation and cannot be predicted precisely for any 
given day. Here, the approximate time of sunset was used to 
establish standardized recommendations for cancellation times of 
outdoor activities during periods of high EEE risk.  
 
This does not eliminate risk nor does it alleviate the 
need for the use of repellants or clothing for 
protection from mosquitoes. 
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